Browsing by Author "Çetin, Y.S."

Now showing 1 - 3 of 3

Brucellosis in the Head and Neck: a Forgotten Differential Diagnosis
(Yuzuncu Yil Universitesi Tip Fakultesi, 2024) Çetin, Y.S.; Dündar, İ.
Introduction: Patients with brucellosis present with nonspecific symptoms originating from different organs. In this study, we aimed to investigate the symptoms related to the head and neck region in patients with brucellosis. Materials and Methods: The retrospective study analyzed 542 patients with a definitive diagnosis of brucellosis who were admitted to our hospital between January 2015 and April 2022 and received outpatient and/or inpatient care. Clinical symptoms localized t o the ear-nose-throat and head and neck regions were evaluated. Results: A neck mass was detected in 52 out of 542 patients included in the study. The prevalence of cervical lymphadenopathy and/or abscess was 9.6%. Only lymphadenopathy was present in 30 (57. 7%) patients, while bo th neck abscess and lymphadenopathy were detected in 22 (42. 3%) patients. No significant difference was found between the two groups with regard to treatment regimens . Mean duration of treatment was 30 ± 22.1 (range, 14-70) days in the lymphadenopathy group and was 22 ± 14.7 (range, 14-60) days in the abscess group. No significant difference was found between the two groups with regard to the length of time to clinical recov ery. Conclusion: Brucellosis affects many regions of the head and neck and c an have a variety of imaging manifestations that mimic benign and malignant lesions. The diagnosis of brucellosis should be considered in the first-line differential diagnosis conducted based on imaging features in patients residing in endemic regions. © 2024, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.
Cavernous Hemangioma in Inferior Concha Presented With Hearing Loss
(Yuzuncu Yil Universitesi Tip Fakultesi, 2018) Çetin, Y.S.; Ari, M.; Bozan, N.
Location of cavernous hemangioma in nasal cavity is a very rare condition. Herein we will report an adult male diagnosed with cavernous hemangioma located in inferior concha and causing otitis media with effusion that was treated with the minimally invasive trans-nasal endoscopic technique. Although there are many options in treatment of lesions in nasal cavity, we recommend the trans-nasal endoscopic approach since it is minimally invasive and it is sufficient in both bleeding control and complete removal of the cavernous hemangioma. © 2018, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.
Comparison of Therapeutic Results of the Starting Time of Hyperbaric Oxygen Therapy in Sudden Sensorineural Hearing Loss
(Yuzuncu Yil Universitesi Tip Fakultesi, 2020) Çetin, Y.S.; Taşdöven, G.E.
This study aimed to assess the impact of the hyperbaric oxygen (HBO) therapy starting time (early or late) on the treatment of idiopathic sudden sensorineural hearing loss (ISSNHL). A retrospective analysis examined 203 patients with ISSNHL between January 2014 and June 2018 at Van Training and Research Hospital. We divided the patients into two groups according to the HBO therapy starting time as follows: early HBO (n = 88) and late HBO (n = 115). The early HBO group demonstrated complete, partial, weak, and no recovery in 21 (23.9%), 15 (17.0%), 17 (19.3%), and 35 (39.8%) patients, respectively. The late HBO group demonstrated complete, partial, weak, and no recovery in 5 (4.3%), 9 (7.8%), 15 (13.0%), and 86 (74.8%) patients, respectively. In addition, 53 (60.2%) and 29 (25.2%) patients in the early and late HBO groups, respectively, responded to treatment, which was statistically significant (P < 0.05). Considering patients with severe and profound hearing loss only, we observed a statistically significant difference in response to treatment between the early and late HBO groups (P < 0.05). The study demonstrates that providing HBO therapy during the first 14 days of the treatment period contributed significantly to treatment success. Therefore, patients with severe and profound hearing loss can significantly benefit by starting HBO therapy at an early stage of the disease. © 2020, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.